COLUMBUS, Wis., July 03, 2025 (GLOBE NEWSWIRE) -- In response to today’s release of the June 2025 employment report, Michael Eisenga, CEO of First American Properties, cautioned policymakers and investors against overconfidence in the labor market’s apparent stability.
NEW YORK, July 3, 2025 /PRNewswire/ -- The promotion and information campaign "Discover the European Cheestories with cheeses from Spain", promoted by the Interprofessional Dairy...
NEW YORK, July 3, 2025 /PRNewswire/ -- The promotion and information campaign "Discover the European Cheestories with cheeses from Spain", promoted by the Interprofessional Dairy...
The global robotic surgery market size is calculated at USD 13.79 billion in 2025 and is expected to reach around USD 54.66 billion by 2034, growing at a CAGR of 16.54% for the forecasted period.
The global robotic surgery market size is calculated at USD 13.79 billion in 2025 and is expected to reach around USD 54.66 billion by 2034, growing at a CAGR of 16.54% for the forecasted period.
LUXEMBOURG, July 3, 2025 /PRNewswire/ -- Adecoagro S.A. (NYSE: AGRO) ("Adecoagro" or the "Company"), a leading sustainable production company in South America and Tether...
TAMPA, Fla., July 3, 2025 /PRNewswire/ -- Verdantas, a leader in digitally enabled technical consulting solutions for the environment, water, and energy transition markets...
OSLO, Norway, July 3, 2025 /PRNewswire/ -- Norway-based browser developer, Opera , is breaking down language barriers for its users with the launch of...
New York City, NY, July 03, 2025 (GLOBE NEWSWIRE) -- In 2025, Nixol, a plant-based dietary supplement, made its debut in the United Kingdom and Ireland, marking a significant entry into the wellness supplement market. Designed to support healthy weight management, boost metabolism, and curb cravings, Nixol has positioned itself as a natural, vegan-friendly alternative to traditional weight loss solutions. Unlike products that rely on synthetic stimulants or restrictive diets, Nixol leverages a blend of carefully selected, science-backed ingredients to promote sustainable fat reduction and overall well-being. This article provides an in-depth exploration of Nixol’s launch, its formulation, claims, scientific backing, customer feedback, and the broader context of its market entry, while critically examining its potential effectiveness and limitations. Visit Official Website
PALO ALTO, Calif., July 3, 2025 /PRNewswire/ -- Recently, the prestigious media platform Caijing Magazine officially unveiled its "Top 50 Global Chinese Venture Capitalists" list....
Union Secures Best-Ever Agreement at Largest Meat Producer in U.S.
AMARILLO, Texas, July 2, 2025 /PRNewswire/ -- Teamsters Local 577 members at Tyson Foods of...
MONTREAL, July 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that it has entered into a binding arrangement agreement with CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products, whereby the Purchaser will acquire all the issued and outstanding common shares of the Company for US$3.01 per share in cash plus one contingent value right (“CVR”) per share for additional aggregate cash payments of up to US$1.19 per CVR if certain milestones as described below are achieved (the “Transaction”). The total Transaction consideration, assuming full payment of the CVRs, is US$254 million.